Clinical Trial Results:
A Phase 2b, Multicenter, Randomized, Double-blind,
Placebo-controlled, Parallel-group Study to Evaluate the Efficacy
and Safety of Ustekinumab Therapy in Subjects with Moderately
to Severely Active Crohn’s Disease Previously Treated with TNF
Antagonist Therapy
Summary
|
|
EudraCT number |
2008-000649-77 |
Trial protocol |
NL DE GB BE ES AT FR |
Global completion date |
09 Dec 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Jun 2016
|
First version publication date |
04 Jun 2016
|
Other versions |
|
Summary report(s) |
C0743T26 (2008-000649-77)_CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.